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Fig. 2 A Sequence of the re­
gion of the coding strand of 
exon 2 in which the deletion is 
found* B Chou-Fasman and 
Garnier-Osguthorpe-Robson 
prediction o f  the polypeptide 
of ARSA. 1 Normal, 2 dele­
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cicncy of the lysosomal enzyme arylsulfatase A (ARSA); 
a few cases have been described in which the decreased 
hydrolysis and subsequent storage of sulfatides is the re­
sult of the absence of the sphingolipid activator protein 
saposin B (Luijten 1991).
in the ARSA gene, 37 different mutations have now
mother. The patient and the father had a heterozygous 
nucleotide (287C—>T) in exon 2 in common (data not 
shown).
The identity of both mutations was secured by cloning 
exon 2 of the patient. As the deletion results in the loss of 
the restriction site of the Saul enzyme, it was possible to
been described, ol which three are deletions (Gieselmann identify which exon 2 had the deletion, by means of re-
et al. 1994). In this paper, we present an MLD patient with 
five different mutations in the ARSA gene.
Patient
The patient* a boy, presented with motor disturbances at the age 
of 12 months. Me never started walking. He gradually developed 
a spastic tetraplegia and mental retardation followed by regres­
sion that ended in a vegetative stale at the age of four. Magnetic 
resonance imaging of the brain showed extensive demyelination. 
On electropbysiological examination of peripheral nerves* a de­
creased conduction velocity was found, indicating a demyelinat­
ing neuropathy. The diagnosis of MLD was made by determi­
nation of the activity of ARSA in leukocytes and cultured fibro­
blasts, and bv determination of the sulfatide excretion in urine 
(Table I ).
Materials and methods
The ARSA gene was amplilied in two fragments (exons 1-4 and 
exons 5~X), by the polymerase chain reaction (PCR), from ge­
nomic DNA of leukocytes. Individual exons with their intron 
boundaries were subsequently amplified, with these two PCR frag­
ments as a template. Primers used lor PCR amplification and se­
quence analysis of exon 2 were: forward primer, 5TTG TC TG TC - 
TCAGGGACTCT3' (nucleotide position; 332-351); reverse primer, 
5TG G G G C TG C G G G A C A G TC A A 3' (nucleotide position: 684- 
665). Nucleotide position refers to gene nucleotide numbering, with 
the A of ATG as no. 1.
Amplimers were subjected to single-stranded conformation 
polymorphism (SSCP) analysis using the Pharmacia Phast System 
(conditions for exon 2; 12.5% polyacrylamide gel, 20°C\ 175 Vh). 
Cycle sequencing of the coding and the noncoding strands of all 
eight exons, and of exon 2 after ligation into the pCR-Script™ 
SK(+) cloning vector, was carried out by the Taq Dye Deoxy Ter­
minator method using an AH I DNA sequencer. The amplimers ob­
tained by PCR amplification of the cloned exon 2 were digested 
with the restriction enzyme .SV///I and with the restriction enzyme 
HstEU as control.
striction enzyme digestion (Fig. 1 B).
Sequencing of the separate alleles of exon 2 demon­
strated two independently inherited mutations: ( 1) In the 
maternal allele, a deletion of 12 bp (cDNA 392-403) (Fig. 
2 A), resulting in one amino acid substitution ( E l 3 IV), 
and a deletion of four amino acids (G132, A133, F134, and 
L I35) were present. (2) In the paternal allele, a 287C—>T 
transition leading to an amino acid substitution (S96F, 
data not shown) was found. In the maternal allele that had 
the deletion, an additional point mutation occurred in 
exon 7 (a 1172C—>G transversion), resulting in an amino 
acid substitution (T391S), a polymorphism described as 
part of the I allele (Polten et al. 1991). A 1049A—>G tran­
sition and a 1620A ^G  transition, the two mutations of 
ARSA pseudodeficiency, were found in the paternal allele 
(data not shown). The finding of the 2 8 7 C ^ T  transition 
on the background of the pseudodeficiency mutations has 
been described previously (Gieselmann et al. 1991). Di­
rect sequencing of the remaining exons demonstrated no 
further mutations.
Secondary structure prediction according to both 
Chou-Fasman 1974 and Garnier-Osguthorpe-Robson 1978 
demonstrated one turn in the normal ARSA molecule 
(Fig. 2Bl )  which has not been found in the ARSA 
polypeptide with the deletion (Fig. 2 B 2).
It can be assumed that the deletion is a disease-causing 
mutation because it is located in the exon 2 and exon 3 re­
gion of the enzyme. This region shows a high degree of 
conservation among sulfatases (Gieselmann et al. 1994). 
The 287C-VT missense mutation has previously been shown
Results and discussion
to lead to a complete loss of enzyme activity in an ex­
pression study (Gieselmann et al. 1991). The deletion was 
not found in twenty other families with MLD investigated 
by means of SSCP analysis of exon 2.
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SSCP analysis of the amplimer of exon 2 of the pa­
tient showed bands not present in the control. One band 
with a shift in mobility was present in the SSCP of the 
patient ami the father, whereas two different bands were 
present in the SSCP of the patient and the mother. The 
SSCP of exon 2 of the patient therefore indicates the pres­
ence of two different mutations on separate alleles (Fig, 
1 A).
Direct sequencing of the eight exons suggested a dele­
tion in one allele of exon 2, both in the patient and the
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